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Summary
Objective: To compare four different implantation modalities for the repair of superﬁcial osteochondral defects in a caprine model using
autologous, scaffold-free, engineered cartilage constructs, and to describe the short-term outcome of successfully implanted constructs.
Methods: Scaffold-free, autologous cartilage constructs were implanted within superﬁcial osteochondral defects created in the stiﬂe joints of
nine adult goats. The implants were distributed between four 6-mm-diameter superﬁcial osteochondral defects created in the trochlea femoris
and secured in the defect using a covering periosteal ﬂap (PF) alone or in combination with adhesives (platelet-rich plasma (PRP) or ﬁbrin), or
using PRP alone. Eight weeks after implantation surgery, the animals were killed. The defect sites were excised and subjected to macroscopic
and histopathologic analyses.
Results: At 8 weeks, implants that had been held in place exclusively with a PF were well integrated both laterally and basally. The repair
tissue manifested an architecture similar to that of hyaline articular cartilage. However, most of the implants that had been glued in place
in the absence of a PF were lost during the initial 4-week phase of restricted joint movement. The use of human ﬁbrin glue (FG) led to massive
cell inﬁltration of the subchondral bone.
Conclusions: The implantation of autologous, scaffold-free, engineered cartilage constructs might best be performed beneath a PF without the
use of tissue adhesives. Successfully implanted constructs showed hyaline-like characteristics in adult goats within 2 months. Long-term
animal studies and pilot clinical trials are now needed to evaluate the efﬁcacy of this treatment strategy.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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A functional articular cartilage layer is crucial for proper joint
functioning. Unfortunately, this tissue is extremely vulnera-
ble to traumatic injury and degeneration, which may lead
to osteoarthritis. This is particularly the case for large,
weight-bearing joints, such as the knee. The spontaneous
repair of damaged cartilage is limited by the tissue’s intrin-
sically poor capacity to regenerate1. Although various surgi-
cal procedures have been developed to overcome this
obstacle, none of these have been successful in regenerat-
ing a normal and functional articular cartilage layer.
Non-aggressive debridement of ﬁbrous/osteoarthritic ar-
ticular cartilage is deemed to be effective in relieving pain
and restoring function in patients with traumatic/degenera-
tive lesions2e5. The procedure may be coupled with micro-
fracturing of the subchondral bone layer in areas of partial
or total cartilage loss6. However, these surgical strategies
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Received 20 May 2005; revision accepted 9 May 2006.12induce the formation of ﬁbrous cartilage, which does not
have the biomechanical competence of the hyaline type.
Mosaicplasty, which involves the transplantation of autol-
ogous osteochondral grafts, has been performed to improve
joint resurfacing7,8. However, donor-site morbidity and the
surgical challenge of the technique have limited its
application.
Newer techniques that have been developed to improve
the quality of cartilage healing include autologous chon-
drocyte injection (ACI)9e14 and the implantation of engi-
neered chondral grafts grown within various scaffold
materials15e28.
We have established a technology to produce the semi-
solid, scaffold-free implants from isolated autologous chon-
drocytes29. Our results with miniature pigs30 and rabbits31
have been encouraging. But it is generally agreed that re-
sults obtained using small animal models have to be veri-
ﬁed in large ones, e.g., the goat.
The success of an engineered cartilage implant will de-
pend not only upon its integrative potential and capacity
to remodel into a functional articular cartilage layer, but
also upon its initial retention. In analogy with the technique
used for ACI, the implant can be trapped beneath an autol-
ogous periosteal ﬂap (PF), which is sutured to the edge of14
1215Osteoarthritis and Cartilage Vol. 14, No. 12the cartilage surrounding the defect. Human ﬁbrin glue
(FG), which is also used in ACI technique, could improve
the retention rate. Platelet-rich plasma (PRP) could be
employed as an autologous alternative to FG, whereby
the adhesive properties of PRP might be enhanced by its
content of growth factors32e34.
The aim of the present study was to compare four different
implantation modalities for the repair of superﬁcial osteo-
chondral defects in a caprine model using autologous scaf-
fold-free cartilage constructs, and furthermore, to describe
the short-term outcome of successfully implanted constructs.
Materials and methods
EXPERIMENTAL ANIMALS
Nine female Saanen goats, 36 months of age with an
average body weight of 60 kg were used in this study.
SURGICAL PROCEDURE FOR THE HARVESTING
OF CHONDROCYTES
The animals were considered healthy on the basis of
physical examination, complete blood count and biochemis-
try proﬁle. The goats received midazolam (0.4 mg kg1
of body weight; Dormicum; Roche Pharma, Reinach,
Switzerland) intravenously (IV) for sedation. Anesthesia
was induced with a combination of ketamin (3 mg kg1 of
body weight; Narkan 100; Dr. E. Gra¨ub AG, Berne,
Switzerland) and propofol (1 mg kg1 of body weight; Pro-
pofol 1% Fresenius; Fresenius Kabi, Stans, Switzerland).
After endotracheal intubation anesthesia was maintained
with 1 minimal alveolar concentration (MAC) (2.3%) end-
tidal sevoﬂurane (Sevorane, Abbot AG, Baar, Switzerland).
Perioperative and postoperative analgesia was achieved by
administering ﬂunixin meglumine (Finadyne, Biokema,
Crissier, Switzerland). Penicillin was administered for perio-
perative antibiosis.
The operation ﬁeld was surgically prepared by clipping
the hair, disinfecting the skin and draping. Cartilage biop-
sies were removed with a scalpel from the right trochlea
femoris by arthrotomy, using a lateral parapatellar approach
to the femoropatellar joint.
CHONDROCYTE CULTURE
These were stored in transport medium (Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) F12) before being weighed
and cut into small pieces. The chondrocytes were extracted
by digesting the tissue ﬁrst with pronase (Boehringer,
Germany; 1 mg/ml; 10 ml/g of tissue) for 1.5 h and then
with collagenase (Boehringer, Germany; 0.25 mg/ml;
10 ml/g of tissue) for 4 h.
IMPLANT PRODUCTION AND ASSESSMENT
To produce the implants, the liberated chondrocytes were
seeded at a density of about 10,000 cells/cm2 and
expanded for 1e2 passages (5e10 days per passage) in
culture dishes containing a proliferation medium containing
DMEM F12, 10% fetal calf serum (FCS) (Life Technologies,
HyClone, UT, USA), vitamin C (50 mg/ml; Fluka,
Switzerland), antibiotics and antimycotics. The cells were
then directly seeded at a density of 20 million cells into a pat-
ented dialysis chamber (EU-Patent Nr. 992093, 1998).
Within these chambers, the cells are seeded betweensemi-permeable membranes that protect the developing
construct from turbulence and the loss of new matrix-
associated molecules during media changes. The cells
were maintained between the upper and lower membranes
(100 kDa) for 12 days and were subsequently cultured out
of the chamber in six-well plates (in free open culture) for
a further 4e6 weeks. Each chamber occupied one well of
a six-well plate (NUNCLON; Nunc, Denmark) with approxi-
mately 10 ml of DMEM supplemented with 10% FCS, insu-
lin (1 mg/ml; Life Technologies), vitamin C and maintained at
standard conditions (37(C, 5% CO2 and 90% humidity).
The media in each well were changed every 2 or 3 days.
Prior to implantation, the quality of the engineered con-
structs was assessed as described earlier by Grogan and
coworkers29 on the basis of their overall external appear-
ance, diameter and stiffness. Construct pieces designated
for histological evaluation were ﬁxed for 24 h in 4% parafor-
maldehyde and were subsequently embedded in parafﬁn.
HematoxylineEosin, Alcian blue, Masson Trichrome and
Safranin-O/fast green staining were performed. The viability
of cells was assessed by using a two-color ﬂuorescence
cell viability assay (Live-Dead, Molecular Probes Inc.,
Eugene, OR, USA). Sections of construct were embedded
in agar (gelling temperature approximately 35(C; Fluka)
while being cut with a tissue sectioner (TC-2 Smith and
Farquhar, Ivan Sorval Inc., CT, USA), producing 230 mm
sections. The sections were maintained in phosphate buff-
ered saline (PBS) before incubation at room temperature
for 1 h in the live/dead reagent consisting of ethidium homo-
dimer (8 mM) and calcein-AM (1 mM) in PBS (Molecular
Probes). The sections were viewed under laser confocal
microscopy (LSM 410, Zeiss, Germany) using excitation
wavelengths of 488 nm, and both red and green ﬂuores-
cence images were detected simultaneously to assess the
proportion of live and dead cells in the section. Total colla-
gen content of each construct was determined spectropho-
tometrically from the hydroxyproline content after alkaline
hydrolysis (4 M NaOH, 120(C, 30 min) and reaction with
p-dimethylaminobenzaldehyde and chloramine T28 using
a calibration curve with known concentrations of gelatin.
To distinguish between individual collagen types, the
method described by Schwartz et al. was used. Brieﬂy,
the samples were homogenized with a grinding mill (6750
Freezer Mill, SPEX Industries GmbH, Grasbrunn, Germany)
and were then subjected to repeated digestion with pepsin
(1 mg/ml, 24 h, 4(C; Sigma, Switzerland) in 0.5 M acetic
acid, 0.2 M NaCl, pH 1.5. After neutralization of the pooled
digests, solubilized collagens were precipitated in 4.5 M
NaCl. The salt-precipitated collagens were separated by
4.5e15% gradient gel electrophoresis, parallel with
standards of pure collagens I, II, IX, X and XI. Following
pretreatment of each sample with papain (1 mg enzyme
per 500 mg tissue in 1 M NaCl, 0.05 M sodium phosphate,
5 mM cysteineeHCl, 10 mM ethylenediamine tetraacetic
acid (EDTA), pH 6.5) for 30 min at 60(C, the digests were
subjected to two consecutive extraction steps (24 h, 4(C)
with 10 volumes of 4 M guanidium chloride, 0.05 M sodium
acetate, pH 5.8. Total proteoglycan content of pooled ex-
tracts was measured using the colorimetric dimethylene
blue (DMB) assay for sulfated glycosaminoglycans
(GAGs)35. The results are reported with reference to equiv-
alents obtained from standard puriﬁed chondroitin sulfate
from shark. Furthermore, immunohistochemistry was per-
formed for collagen types I and II. Tissue samples were
ﬁxed for 24 h with 4% paraformaldehyde, embedded in
parafﬁn and were cut into 4 mm thick sections. After pre-
treatment with 1 mg/ml chondroitinase, sections were
1216 W. Brehm et al.: Repair of superﬁcial osteochondral defectsFig. 1. Details of surgery. (A) Superﬁcial osteochondral defects created in the trochlea femoris of a goat. A variable degree of tidemark opening
occurred in all defects. Although some bleeding points are visible, hemorrhaging was minimal. (B) An engineered cartilage implant is placed
beneath the PF, which, for technical reasons, was ﬁrst secured with three knots. (C) Superﬁcial osteochondral defect covered with a PF, which
was secured to the surrounding cartilage with 8e10 simple knots (7e0 PDS II).incubated with monoclonal primary antibodies for collagen
type I (Quartett, Berlin, Germany) and collagen type II (II-
II6B3, Hybridoma Bank, University of Iowa, USA). The
slides were then incubated with a biotinylated goat anti-
mouse secondary antibody for 35 min followed by
StrABC/AP for 45 min (DAKO, Denmark). Bound
antibodies were made visible by means of New Fuchsin/
Naphthol AS-BI substrate (Sigma Chemical Co.,
Switzerland).
IMPLANTATION PROCEDURE
In a second surgical intervention, the engineered
cartilage implants derived from each goat were distributed
between four 6-mm-diameter superﬁcial osteochondral de-
fects (about 0.8 mm in depth) [Fig. 1(a)] created in the left
trochlea femoris of the donor animal. This type of defect is
characterized by the removal of hyaline cartilage until
a thin, discontinuous layer of mostly calciﬁed cartilage,
whereby small bleeding points can be observed. Custom-
built instruments including a drill with ﬂat tip and a cutting
case were used to generate a reproducible fresh defect
for treatment. The general surgical procedure was identical
to that described for the harvesting of biopsies. Four treat-
ment groups were established (Table I):
Group 1: PRP
Autologous PRP was used to secure the implant to the
underlying bone (8 defects in 2 goats).
Group 2: Periosteal flap and fibrin glue (PF/FG)
The implant was secured to the underlying subchondral
bone with Tissucol (human FG) and then trapped
beneath a PF (8 defects in 2 goats) [Fig. 1(b)].
Group 3: Periosteal flap and platelet-rich plasma (PF/PRP)
The implant was glued to the underlying subchondralbone with PRP and trapped beneath a PF (8 defects in
2 goats) [Fig. 1(b)].
Group 4: PF
The implant was trapped beneath a PF derived from the
proximal tibia (12 defects in 3 goats) [Fig. 1(b)].
The PFs were harvested from the ipsilateral proximo-
medial tibia. PRP was prepared from fresh autologous
blood on site using a SmartPReP centrifuge (Harvest
Technologies). Human FG was purchased as a ready-for-
use preparation (Tissucol, Baxter).
Both PRP and FG were applied to the ﬂoor of the super-
ﬁcial osteochondral defect before introducing the implant.
The total volumes of FG or PRP applied were approxi-
mately 0.4 ml per defect.
The PF was placed on top of the implant and secured
with 8e10 simple knots of 7e0 United States Pharmacopoe
Polydioxanon (USP PDS) [Fig. 1(c)]. The wounds were
closed layer by layer using Vicryl 2e0 sutures. Skin adap-
tation was achieved using Monocryl 4e0 sutures.
A full-limb cast was applied for 4 weeks, restricting the
range of motion of the stiﬂe joint to about 5(36, but not
restricting the weight bearing of the limb, and with minor re-
striction of the walking activity of the goats. All defect sites
were then monitored by magnetic resonance imaging (MRI)
(AIRIS II, 0.3 T, Hitachi) and arthroscopy (4 mm, 70( arthro-
scope, Tricam camera system, Karl Storz, Germany) under
general anesthesia. During the ensuing 4 weeks the goats
were put out to pasture and were allowed free movement.
The defect sites were then, again monitored by MRI and ar-
throscopy (again under general anesthesia) before killing
the animals with a lethal dose of pentobarbital.
SAMPLE PREPARATION AND ASSESSMENT
The defect sites were excised, ﬁxed in 4% buffered for-
malin for 96 h, decalciﬁed and embedded in parafﬁn.Table I
Relevant information regarding the four different treatment groups
Group 1 (PRP) Group 2 (PF/FG) Group 3 (PF/PRP) Group 4 (PF)
Cover e PF PF PF
Graft Engineered cartilage Engineered cartilage Engineered cartilage Engineered cartilage
Interface PRP FG PRP e
No. of goats 2 2 2 3
No. of defects 8 8 8 12
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Variables and grading system
Macroscopic ﬁndings on explantation
Variable Comment
FillM Quality of ﬁlling material on macroscopic evaluation
1¼ no ﬁlling
2¼ other than granular tissue or cartilage-like tissue
3¼ ﬁbrous, granular tissue (not ﬂap)
4¼mostly reddish; hematoma
5¼mostly white and similar to surrounding host
cartilage
FlLoM Flap loosening on macroscopic evaluation
1¼ ﬂap in joint but not on defect
2¼ ﬂap loosening
3¼ ﬂap partially in place
4¼ ﬂap in place
ImpLoM Loosening of the engineered cartilage implant
1¼ in joint but not on defect
2¼ not identiﬁable, lost
3¼ partially in place
4¼ in place
ICRSM Combination of ICRS scoring system for defect repair
0¼ implants are lost or broken/no repair of defect depth
1¼ 25% survival of initially grafted area/repair of defect
depth
2¼ 50% survival of initially grafted area/repair of defect
depth
3¼ 75% survival of initially grafted area/repair of defect
depth
4¼ 100% survival of initially grafted area/repair of de-
fect depth
IntegrM Integration of repair material with the border zone
0¼ from no contact to 1/4 of graft integrated with sur-
rounding cartilage
1¼ 1/2 of graft integrated, 1/2 with a notable border
>1 mm
2¼ 3/4 of graft integrated, 1/4 with a notable border
>1 mm
3¼ demarcating border <1 mm
4¼ complete integration with surrounding cartilage
SurfM Architecture of the surface
0¼ total degeneration of the grafted area
1¼ several small or a few large ﬁssures
2¼ small, scattered ﬁssures and cracks
3¼ ﬁbrillated surface
4¼ intact smooth surface
ICRS Overall ICRS repair assessment
1¼ grade I (12)
2¼ grade II (11e8)
3¼ grade III (7e4)
4¼ grade IV (3e1)
InfM Visible signs of inﬂammation within joint cavity
1¼ no inﬂammation
2¼ slight inﬂammation
3¼ strong inﬂammation
OsPhy Visible osteophyte formation
1¼ absent
2¼ discrete
3¼moderate on one side
4¼ all around but moderate or on one side but
prominent
5¼ severe all around
Histologic ﬁndings
FlH Flap loosening/retention
4¼ in place
3¼ partially in place
2¼ loosening
1¼ in joint but not on defectTable II (continued)
Macroscopic ﬁndings on explantation
Variable Comment
ImpH ICRS protocol, modiﬁed for histology
1¼ implants are lost or broken/no repair of defect depth
2¼ 25% survival of initially grafted area/repair of defect
depth
3¼ 50% survival of initially grafted area/repair of defect
depth
4¼ 75% survival of initially grafted area/repair of defect
depth
5¼ 100% survival of initially grafted area/repair of
defect depth
Ti Tissue morphology
4¼mostly hyaline cartilage
3¼mostly ﬁbrocartilage
2¼mostly non-cartilage
1¼ exclusively non-cartilage
Matx Matrix staining
1¼ none
2¼ slight
3¼moderate
4¼ strong
Stru Structural integrity
1¼ severe disintegration
2¼ cysts or disruptions
3¼ no organization of chondrocytes
4¼ beginning of columnar organization of chondrocytes
5¼ normal, similar to healthy mature cartilage
Clus Chondrocyte clustering in implant
1¼ 25e100% of the cells clustered
2¼<25% of the cells clustered
3¼ no clusters
Tide Intactness of the calciﬁed cartilage layer, formation of
tidemark
1¼<25% of the calciﬁed cartilage layer intact
2¼ 25e49% of the calciﬁed cartilage layer intact
3¼ 50e75% of the calciﬁed cartilage layer intact
4¼ 76e90% of the calciﬁed cartilage layer intact
5¼ complete intactness of the calciﬁed cartilage layer
Bform Subchondral bone formation
1¼ no formation
2¼ slight
3¼ strong
BfImp Bone formation within implant or cartilage
1¼ no formation
2¼ slight
3¼ important
SurfH Histologic appraisal of surface architecture
1¼ severe ﬁbrillation or disruption
2¼moderate ﬁbrillation or irregularity
3¼ slight ﬁbrillation or irregularity
4¼ normal
FilH Histologic appraisal defect ﬁlling
1¼<25%
2¼ 26e50%
3¼ 51e75%
4¼ 76e90%
5¼ 91e110%
LatI Lateral integration of implanted material
1¼ not bonded
2¼ bonded at one end/partially both ends
3¼ bonded at both sides
BasI Basal integration of implanted material
1¼<50%
(continued on next page)
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with four cuts per level, using a motorized microtome
(Leica RM2165). The tissue slices were stained with Hem-
atoxylineEosin, Safranin-O, MassoneGoldner Trichromic
or Alcian blue prior to histological evaluation in a light micro-
scope (Leica Leitz, Germany) using a modiﬁed version of
the grading system developed by O’Driscoll, Keeley and
Salter (Table II)37,38. Each section embraced the entire
height and breadth of the defect, including the articular sur-
face, the native cartilage at each side and the underlying
subchondral bone. Since all sections passed through the
center of the defect, they were considered to be represen-
tative of the central area and the margins, thereby ensuring
a homogeneous and comprehensive evaluation39.
Before embarking on the histological evaluation, the
defect sites were inspected macroscopically with a view to
ascertaining whether the PFs and the implants had been re-
tained. Hereby, the presence of ﬁbrous strands in the defect
gave was an important visual sign for the retention of peri-
osteal material, while the underlying engineered constructs
were difﬁcult to appraise macroscopically. Overall defect
ﬁlling on the other hand, which includes both implanted ma-
terial and repair tissue originating in the natural healing pro-
cess, was appraised using the ICRS scoring system (Table
II, ICRSM: survival/repair of the defect).
The following histologic variables were used to assess
the defect sites: tissue morphology (Ti), matrix staining
(Matx), structural integrity (Stru), cluster formation (Clus),
tidemark opening (Tide), bone formation (Bform), histologic
surface architecture (SurfH), histologic degree of defect ﬁll-
ing (FilH), lateral integration of defect-ﬁlling tissue (LatI),
basal integration of defect-ﬁlling tissue (BasI), and histo-
logic signs of inﬂammation (InfH). The grades for each vari-
able were then combined to yield an overall histologic
grading value (Hgtot).
Finally, the cellularity of the subchondral bone and the
degree to which it had been remodeled were determined
Table II (continued)
Macroscopic ﬁndings on explantation
Variable Comment
2¼ 50e70%
3¼ 70e90%
4¼ 91e100%
InfH Inﬂammation
1¼ no inﬂammation
3¼ slight inﬂammation
5¼ strong inﬂammation
Hgtot Histological grading system
Some of the histologic variables: tissue morphology
(Ti), matrix staining (Matx), structural integrity (Stru),
cluster formation (Clus), tidemark opening (Tide),
bone formation (Bform), histologic surface architecture
(SurfH), histologic degree of defect ﬁlling (FilH), lateral
integration of defect-ﬁlling tissue (LatI), basal integra-
tion of defect-ﬁlling tissue (BasI), and histologic signs
of inﬂammation (InfH)
Maximum total: 45 points
Remod Subchondral bone remodeling (loosely textured highly
cellular tissue composed of mostly ﬁbroblasts)/
cellularity
1¼ no remodeling
2¼ discrete cellularity
3¼moderate cellularity
4¼ high cellularityas a measure of secondary reactions to the implantation
technique (Remod).
STATISTICS
Statistical analyses were performed using a commercial
package (NCSS, Kaysville, Utah). Each defect was
considered as an independent observation. The adoption
of this procedure is supported by the poor correlation
existing between tissue type in an individual defect and its
location within the joint27. The signiﬁcance of associations
between variables (set at P< 0.05) was determined using
the chi-square test. Mean values are presented together
with the standard deviation (StdDV) (Tables IIIeV).
Results
An autologous cartilage construct, with a wet weight of
38.6 (20.2) mg, a diameter of 8 mm and a thickness of
1 mm, could be prepared from each biopsy. Representative
engineered grafts were found to have a collagen content of
30.6 (6.6) mg/g of tissue and a chondroitin sulfate content
of 15.8 (6.1) mg/g of tissue, the respective values for
native cartilage being 61 0.74 mg/g (collagen) and
20 0.68 mg/g wet weight tissue (GAG). Histology of the
constructs (Fig. 2) revealed the engineered tissue to have
a high cellularity, comparable to that in fetal cartilage. The
extracellular matrix stained intensely with Safranin-O
(Fig. 2), indicating the presence of abundant GAGs. Immu-
nohistochemical staining for collagen type I was very weak,
while it was intense for collagen type II. Within the engi-
neered cartilage tissue, at least 90% cell viability could be
ascertained as assessed by confocal microscopy (data
not shown).
The surgery was well tolerated. No postoperative prob-
lems were encountered other than occasional subcutane-
ous seromas and slight pressure sores, which were
caused by the casts. These complications did not affect ei-
ther the behavior of the goats or weight bearing, and stiff-
ness was not observed in any of the goats.
Postoperatively, the defect sites were monitored at 4
and 8 weeks using MRI and arthroscopy. Although MRI
was of use in identifying subchondral edema, the resolu-
tion was too poor either to permit a distinction between
the implants and the surrounding tissue or to reveal
whether the implants had been retained. Arthroscopy
was more informative. Arthroscopic inspection of the
defect sites 4 and 8 weeks after surgery revealed a similar
appearance at each juncture (Fig. 3). Hence, if an implant
Table III
Results of the macroscopic evaluation (mean StdDV; see Table II
for an explanation of the abbreviations)
PRP
(group 1)
n¼ 8
PF/FG
(group 2)
n¼ 8
PF/PRP
(group 3)
n¼ 8
PF
(group 4)
n¼ 12
FillM 3 0.53 2.9 2.03 3.8 1.04 4.5 0.90
FlLoM (no ﬂap) 2.1 0.35 2.9 0.99 3.1 0.79
ImpLoM 2.5 0.76 2.6 0.92 3.1 0.83 3.5 0.67
ICRSM 0.6 1.06 1.5 1.85 2.1 1.73 3.4 0.90
IntegrM 0.4 1.06 1 1.41 1.8 1.91 3 0.95
SurfM 1.4 1.19 0.9 1.25 1.5 1.31 2.3 1.15
ICRS 3.6 0.74 3.4 0.92 3 0.93 2.3 0.75
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restricted motion, it was not subsequently lost when the
joint was freely moveable and fully loaded. Postmortem
macroscopic inspection of the defect sites conﬁrmed the
arthroscopic ﬁndings relating to defect ﬁlling, retention of
the PF and the appearance of the defect surface.
Table IV
Results of the histologic evaluation (mean StdDV; see Table II for
an explanation of the abbreviations)
PRP
(group 1)
n¼ 8
PF/FG
(group 2)
n¼ 8
PF/PRP
(group 3)
n¼ 8
PF
(group 4)
n¼ 12
FlH (no ﬂap) 2.9 0.35 3.8 0.71 4 0
ImpH 1.8 0.71 1.3 0.46 4 1.20 3.8 0.94
Ti 2 1.07 1.4 0.52 3.5 0.53 3.2 0.72
Matx 1.6 0.52 1.1 0.35 3.1 0.83 2.6 0.51
Stru 1.8 0.89 1 0 3.4 0.52 3.4 0.51
Clus 1.4 0.52 1 0 2.6 0.52 2.3 0.65
Tide 2.6 1.19 2.5 1.07 1.3 0.46 1.2 0.39
Bform 1 0 1.3 0.71 1 0 1 0
SurfH 1.5 0.76 1 0 2.8 0.71 2.8 0.45
FilH 1.9 0.64 1.6 0.74 3.9 1.36 3.8 1.11
LatI 1.8 0.71 1.8 0.71 2.9 0.35 2.9 0.29
BasI 1.5 1.07 1 0 3.3 1.39 3.6 0.79
InfH 2.8 1.29 2.8 1.67 1.8 1.04 3.8 1.03
Hgtot 19.8 3.41 16.4 2.20 29.4 4.50 30.6 4.10
Remod 2 1.07 3.8 0.46 1.6 0.52 1.6 0.51
Table V
The influence of surgical factors on macroscopic and histologic
outcome variables. Associations were calculated by chi-square
testing. Associations are denoted as significant (S, P< 0.05) or
highly significant (HS, P< 0.01). NS is used to denote clear tenden-
cies, which are not significant. Arrows indicate negative (Y) or
positive associations ([). (see Table II for an explanation of the
abbreviations)
PF Adhesive
(PRP or FG)
Xenogeneic
material (human FG)
Macroscopy
FillM [S YHS
FlLoM No calculation YS YHS
ImpLoM [NS YS YHS
ICRSM [NS YS
IntegrM [NS YS
SurfM [NS YHS
ICRS
Histology
FlH No calculation YS YHS
ImpH [NS YS YHS
Ti YHS
Matx YS YHS
Stru [S YS YHS
Clus YS YHS
Tide [S YS YHS
Bform
SurfH [NS YS YHS
FilH YS YHS
LatI [S YS YHS
BasI YS YHS
Blys YHS
InfH YS
Hgtot
Remod YHS
Necr YHSMACROSCOPIC AND HISTOLOGIC EVALUATION
An overview of the grading system is given in Table II.
The results are summarized in Tables III and IV, and visu-
ally exempliﬁed in Fig. 3.
OUTCOME OF IMPLANTATION
Outcome of implantation in group 1: PRP (n¼ 8)
According to the macroscopic observation, the implant
was retained by 1 of the 8 defects, partially retained by
2/8, and completely lost from 5/8 (mean score: 2.5). Accord-
ing to the ICRS macroscopic scoring system, 6 of the 8
defects qualiﬁed for the worst grade of 4, 1/8 for grade 3,
and 1/8 for grade 2 (mean score: 3.6). Histology revealed
that the implants were lost from 3 of the 8 defects, and in
these, no repair was detected. The implant was completely
retained (grades 5 and 4) in none of the 8 defects, partially
retained (grades 3 and 2) in 5/8 and lost from 3/8 (mean
score: 1.8). The mean overall histologic grading value was
19.8/45 (range: 14e24 points). Remodeling was classiﬁed
intense in 1 of the 8 defects, moderate in 1/8, discrete in
3/8, and not present in another 3 of the defects (mean
score: 2).
Outcome of implantation in group 2: PF/FG (n¼ 8)
According to the macroscopic observation, the PFs were
not completely retained by any of the defects. In one in-
stance the ﬂap was partially retained, but in the other 7 de-
fects detached (mean score: 2.1). The implant was either
partially or completely retained within 3 of the 8 defects,
while it was lost from the defect in 5/8 (mean score: 2.6).
According to the ICRS macroscopic scoring system, 5 of
the 8 defects were classiﬁed as grade 4, 1 as grade 3,
and 2 as grade 2 (mean score: 3.4). Histology revealed
that the PFs were partially retained by 7 of the 8 defects,
and delaminated from 1, but they were not completely re-
tained in any instance (mean score: 2.9). The implant was
completely retained (grades 5 and 4) in none of the 8 de-
fects, partially retained (grades 3 and 2) in 2/8 and lost
from 6/8 (mean score: 1.3). The mean overall histologic
grading value was 16.4/45 (range: 13e19 points). Remodel-
ing was classiﬁed intense in 6 of the 8 defects and moder-
ate in the remaining 2 (mean score: 3.8).
Outcome of implantation in group 3: PF/PRP (n¼ 8)
According to the macroscopic observation, the PFs were
completely retained by 3 of the 8 defects, partially retained
by 1, and completely lost from 4 (mean score: 2.9). The im-
plant was completely retained by 3 of the 8 defects, partially
retained by a further 3, and lost from 2 (mean score: 3.1).
According to the ICRS macroscopic scoring system, 3 of
the 8 defects were classiﬁed as grade 4, 2 as grade 3,
and 3 as grade 2 (mean score: 3). Histology revealed
that the PFs were retained by 7 of the 8 defects, and lost
from 1 (mean score: 3.8). The implant was completely re-
tained (grades 5 and 4) in 5 of the 8 defects, partially
retained (grades 3 an 2) in 3/8 and lost from none (mean
score: 4). The mean overall histologic grading value was
29.4/45 (range: 20e33 points). No moderate or intense re-
modeling of the subchondral bone was observed in any of
the defects. Remodeling was classiﬁed intense or moderate
in none of the cases, it was discrete in 5 of the 8 defects,
and not present in 3/8 (mean score: 1.6).
1220 W. Brehm et al.: Repair of superﬁcial osteochondral defectsFig. 2. Photomicrograph of a caprine engineered cartilage construct. A: Staining Safranin-O/fast green, magniﬁcation 100. B: Staining
Safranin-O/fast green, magniﬁcation 400. The homogenous distribution of polysulfated proteoglycans and the shape of the lacunated cells
characterize the cartilaginous tissue type. C: Staining collagen type I, magniﬁcation 200. D: Staining collagen type II, magniﬁcation 200.
While the staining intensity for collagen type I is very weak (C), staining for collagen type II is intense (D). This conﬁrms the engineered
constructs to be cartilage-like in type.Outcome of implantation in group 4: PF (n¼ 12)
According to the macroscopic observation, the PFs were
partially or completely retained by 9 of the 12 defects and
lost from 3 (mean score: 3.1). The implant was completely
retained by 7 of the 12 defects and partially retained by a fur-
ther 4, while it was lost from 1 (mean score: 3.5). According
to the ICRS macroscopic scoring system, 1 of the 12 de-
fects was classiﬁed as grade 4, 2 as grade 3, 8 as grade
2, and 1 as grade 1 (mean score: 2.3). Histology revealed
that the PF was retained by all of the defects (mean score:
4). The implant was completely retained (grades 5 and 4) in
8 of the 12 defects, partially retained (grades 3 and 2) in
4/12 and lost from none (mean score: 3.8). The mean over-
all histologic grading value was 30.6/45 (range: 24e37
points). No moderate or severe remodeling of the subchon-
dral bone was observed in any of the defects. Remodeling
was classiﬁed intense or moderate in none of the 12
defects, it was discrete in 7/12, and not present in 5 of
the defects (mean score: 1.6).
A comparison of the four groups revealed the results in
group 4 (PF) to be better than those in group 3 (PF/PRP),
which in turn were better than those in either group 2 (PF/
FG) or group 1 (PRP). Signiﬁcant associations (P < 0.05)
between the assignment to a speciﬁc treatment group and
the outcome were found for the following macroscopic vari-
ables: ﬁlling of the defect (FillM), retention of the periosteal
ﬂap (FlLoM), retention of the implant as a whole (ImpLoM),
macroscopic ICRS score (ICRSM), integration of the im-
planted material with the surrounding cartilage (IntegrM), ap-
pearance of the defect surface (SurfM), and ICRS score for
cartilage assessment (ICRS) (Table III); and for the following
histologic variables: periosteal ﬂap retention (FlH), implant
retention (ImpH), overall histologic scoring (Hgtot), and
remodeling of the subchondral bone (Remod) (Table IV).ANALYSIS OF FACTORS INFLUENCING OUTCOME
The application of a PF to secure the implants in place
was very effective. In the one group in which no PF was
applied (group 1: PRP), the implant was not completely re-
tained by any of the 8 defects. Eight weeks after surgery,
the surface of each defect in group 1 was covered with
a thin layer of ﬁbrin (Fig. 3). The application of a PF had
no statistical inﬂuence on variables that are not directly re-
lated to the presence of the implant and of the periosteal
material, i.e., it did not have an impact on either the ICRS
macroscopic score (ICRSM), the histologic appearance of
implant retention (ImpH), tissue quality (Ti), matrix formation
(Matx), cluster formation (Clus), histologic appearance of
the defect surface (SurfH), ﬁlling of the defect (FillH), basal
integration (Bas), signs of inﬂammation (InfH), bone lysis
(Blys), bone remodeling (Rem), or signs of bone necrosis
(Necr). Implant loosening (ImpLoM, ImpLoH) tended to
occur more frequently in the group without a PF, but the
difference was not signiﬁcant.
Signiﬁcantly better results were achieved in the PF
groups than in the PRP group for variables that were
directly related to implant retention, namely, macroscopic
defect ﬁlling ((FillM) (P < 0.01)), implant structure ((Stru)
(P < 0.014)), tidemark intactness ((Tide) (P < 0.043)) and
lateral integration ((LatI) (P < 0.018)).
The application of an adhesive was not advantageous.
Both the lateral and basal integrations of the implant, as
well as its retention, were far better, when the engineered
cartilage construct was inserted alone (group 4, PF), with-
out the aid of a gluing agent. As a mode of implant ﬁxation,
PRP in combination with a PF (group 3, PF/PRP) was less
effective than a PF alone. No severe adverse reactions of
the subchondral bone to PRP were observed, but implant
retention and integration were less good in the PF/PRP
1221Osteoarthritis and Cartilage Vol. 14, No. 12Group 1 (PRP) Group 2 (PF/FG) Group 3 (PF/PRP)  Group 4 (PF) 
Arthroscopy 4 weeks 
Arthroscopy 8 weeks 
Histology/Masson-Goldner Trichromic, x 12,5 
Fig. 3. Arthroscopic controls and histology. The ﬁrst row of images depicts representative examples of arthroscopic controls 4 weeks after im-
plantation. The second row of images depicts the same defects 8 weeks after implantation. In the third row, histologic images of the respective
defects are depicted. Group 1 (PRP): Arthroscopic control after 4 weeks yields evidence of implant loss from the defect, which is recognized by
its sharp edge, and central indentation (produced by the drill bit). After 8 weeks, the defect is less clearly demarcated, but the central indentation
is still visible. Histology reveals a thin layer of ﬁbrous tissue, which enters the subchondral bone in the region of the central indentation. Cellular
inﬁltration in the subchondral compartment is not observed. Group 2 (PF/FG): Arthroscopic control after 4 weeks yields evidence of PF detach-
ment and loss of the cartilaginous implant. The defect is clearly identiﬁable. Some suture material is visible in the defect. After 8 weeks, the
defect area is less clearly demarcated. The suture material is still visible. Histology reveals a thin layer of ﬁbrous tissue. In contrast to group 1,
the subchondral bone shows intense cellular inﬁltration, consisting mainly of mononucleated cells. Group 3 (PF/PRP): Arthroscopic control after
4 weeks reveals the presence of a ﬁbrous layer (the PF), which is elevated above the level of the surrounding cartilage and covers the defect.
After 8 weeks, the ﬂap is still present; the surface is somewhat smoother than at 4 weeks. Histology reveals the presence of the PF and of the
cartilaginous implant. Cell inﬁltration of the subchondral bone is moderate. Group 4 (PF): Arthroscopic control after 4 and 8 weeks reveals the
presence of a white material, which is elevated above the level of the surrounding cartilage and covers the defect. Histology reveals the pres-
ence of the PF and of the cartilaginous implant. Cell inﬁltration of the subchondral bone is minimal. Note: The differences in the appearance of
the subchondral bone surface are partly due to surgical variability upon creation of the defects, while the variability in the periosteal cover
(groups 3 and 4) is partly due to the differences in the primary material, which was harvested upon surgery.group than in the PF one. The use of xenogeneic ﬁbrin as
a glue led to massive cell inﬁltration of the subchondral
bone (Fig. 3). Implant retention was also extremely low in
the PF/FG group. The application of an adhesive (PRP or
FG) had no signiﬁcant inﬂuence on either the macroscopic
appearance of defect ﬁlling (FillM), the macroscopic
appearance of the defect surface (SurfM) or signs of inﬂam-
mation (InfM). However, ﬂap retention (FlLoM) was signiﬁ-
cantly higher when no adhesive was applied. The
histologic appearance of defect ﬁlling (FillH) and the histo-
logic appearance of tissue quality (Ti) were also better
when no adhesive was applied. Although bone formation
(Bform) and histologic signs of subchondral bone lysis
(Blys), remodeling (Remod) and necrosis (Necr) were not
signiﬁcantly associated with the presence of an adhesive,
remodeling of the subchondral bone was more intense in
the groups treated with FG or PRP (groups 1, 2 and 3)
than in group 4 (PF). However, the most intense remodelingoccurred in group 1 (PRP, no PF). Apparently, it is not the
interface per se but its nature that provokes an adverse
reaction.
The application of xenogeneic (human) FG as an adhe-
sive had deleterious effects. Xenogeneic material is always
liable to cause an adverse reaction in the host. And in our
study, the worst results for many variables were achieved
in group 2 (PF/FG). In assessing the inﬂuence of FG, group
1 (PRP, no PF) was excluded from the statistical analysis.
Macroscopic repair of the defect depth and the integration
of defect-ﬁlling material were not signiﬁcantly associated
with the application of FG, probably because some sponta-
neous ﬁlling always occurs. Hence, the overall ICRS score
was not signiﬁcantly correlated with the application of FG.
Macroscopic and histologic signs of inﬂammation within
the joint, and histologic signs of bone formation were like-
wise not associated with the use of this gluing agent. How-
ever, signiﬁcant correlations were found for the following
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implant retention, and appearance of the defect surface;
and for the following histologic variables: ﬂap retention,
repair of defect depth, tissue quality, matrix formation, struc-
ture of the defect-ﬁlling material, cluster formation, tidemark
opening, appearance of the defect surface, ﬁlling of the de-
fect, lateral and basal integrations of defect-ﬁlling material,
bone lysis, subchondral bone remodeling and bone necro-
sis (Table V). Hence, human FG had an extremely deleteri-
ous effect both on implant integration and defect healing.
The most important differences between the four treat-
ment groups may be summarized as follows:
1. The application of a PF to secure the engineered
cartilage graft in situ was important during the initial
postoperative phase of restricted joint movement.
2. The application of an adhesive (PRP or FG) between
the graft and the subchondral bone did not improve
the retention or integration of the implant.
3. The application of a xenogeneic adhesive (human FG)
elicited the worst results with respect to implant inte-
gration, defect repair and secondary effects on the
subchondral bone.
4. The best results were achieved when a PF was
applied alone, without the supplementary use of an ad-
hesive agent, which interferes with the intimate contact
established between the implant and the underlying
subchondral bone.
HISTOLOGIC REMODELING AND INTEGRATION OF THE
ENGINEERED CARTILAGE IMPLANT
Defects with ImpH grades of 4 or 5 (75e100% survival of
the graft) were included in this analysis. Hence, 13 defects
(8 from group 4 (PF) and 5 from group 3 (PF/PRP)) were
evaluated. Macroscopic observations at explantation indi-
cated that the PFs were completely retained by 6, partially
retained by 5 and completely lost from 2 of these 13 de-
fects. Macroscopic observations at explantation revealed
9 of 13 engineered grafts to be completely retained, 2 grafts
to be partially retained and 1 graft to be lost from the defect.
In 1 of the defects, the ICRS score was grade I and in a fur-
ther 9 of the defects, the ICRS score was grade II, the mac-
roscopic appearance being very favorable.
Histologic observations revealed, in contrast to the mac-
roscopic evaluation, the ﬂaps to have been retained at least
partially by all 13 defects. The tissue morphology was ﬁbro-
cartilaginous (grade 3) in 5/13 cases displaying mostly
highly cellular connective tissue consisting of loosely tex-
tured coarse ﬁbers (high proportions of type I collagen). Tis-
sue morphology was of hyaline character (grade 4) in eight
cases with high cellularity of rounded chondrocytes embed-
ded in inhomogeneous matrix (Figs. 4 and 5). The matrix
staining was moderate (grade 3) in 9 of the 13 defects. In
only one instance was a weak staining (grade 1) recorded.
The structure of the defect-ﬁlling material revealed no orga-
nization of the chondrocytes (grade 3) in 5 and beginning
columnar reorganization [grade 4, Fig. 4(C)] in 8 of the 13
defects. Cluster formation was generally not observed.
The tidemark was opened in most instances. Bone forma-
tion was observed in none of the defects. Histologic grading
of the defect surface showed slight ﬁbrillation or irregularity
(grade 3) in all cases. Defect ﬁlling was complete (grade 5)
in eight cases and nearly complete (grade 4) in four in-
stances. Lateral and basal integrations were generally
very good (Fig. 5), and in cases, where lateral integration
and basal integration were present, fusion of the lateraland deep interfaces could be observed in all but 25% of
the cases. However, basal integration was not always opti-
mal in group 3 (PF/PRP, 5 defects), as evidenced by the
presence of narrow gaps between the cartilaginous implant
and the subchondral bone. The overall histologic grade
ranged between 29/45 and 37/45 points, no differences
could be observed in the global histologic assessment of
groups 3 and 4, however. Remodeling and cellularity of
the subchondral bone were low (graded 1 or 2).
Eight weeks after implantation, the grafts had undergone
beginning remodeling toward articular cartilage, as the
chondrocytes were partially organized in vertical columns
[Fig. 4(D)]. The PFs had not undergone transformation at
this stage. Periosteal hypertrophy was not observed at
this juncture (Fig. 4).
Discussion
The goat is a large animal model, which is widely used in
cartilage repair studies36,40e44. Since juvenile animals have
a greater regenerative capacity than mature ones, we used
adult goats to avoid overestimating the therapeutic potential
of our treatment strategy. We uniformly used female goats.
And while the sexual status of the animal has an inﬂuence
on articular cartilage, as reported for the sheep45,46, we
estimate this inﬂuence to be small in comparison to the
inﬂuence of joint surgery as such.
Earlier experiments of our own have revealed the PF
retention rate to be highest in the trochlea femoris47, and
we thus chose this region for our implantation site.
The production of scaffold-free neo-cartilage of large size
has previously been reported using chondrocytes from the
pig29,38, the rabbit31 and the horse48. The constructs from
caprine chondrocytes used in our study were variable in
wet weight, and this variability should be reduced to obtain
uniform conditions for cartilage repair. In all species, the
neo-cartilage was hyaline in structure, with cell densities
well above the level of mature cartilage. Total collagen con-
centrations were at 50e60% of normal hyaline cartilage,
while the proteoglycan concentrations reached 75e100%
of the reference values. As a major advantage of scaffold-
free material over biodegradable scaffolds, effects of degra-
dation products or biological effects of the foreign material
used can be avoided.
Superﬁcial osteochondral defects resemble commonly
encountered defects in human patients following debride-
ment. In a clinical setting, these lesions are debrided before
treatment, and in this debrided state they correspond to the
superﬁcial osteochondral defects artiﬁcially created in our
animal model. A similar model has been described in goats
for the investigation of ACI by other investigators39. These
authors claimed that in defects with a depth of 0.8 mm,
almost the entire thickness of the hyaline cartilage tissue
is removed, leaving behind a thin, discontinuous layer of
mostly calciﬁed cartilage. The discrete, microscopic viola-
tions of this layer afford limited access to the underlying
subchondral bone and bone marrow. This situation corre-
sponds to the small bleeding points observed in our defect
model; hence the designation ‘‘superﬁcial osteochondral’’.
We chose a defect diameter of 6 mm, which exceeds the
upper limit for spontaneous repair49. Defects of 3 mm have
been reported to spontaneously regenerate both in goats50
and horses51.
Our results demonstrate that the entrapment of an engi-
neered cartilage implant within the defect space by means
of a PF is necessary for its retention. We have not deﬁned
1223Osteoarthritis and Cartilage Vol. 14, No. 12Fig. 4. Histology of a successfully implanted cartilage construct in group 4 (PF). (A) MassoneGoldner Trichromic stain (MAS), 12.5: The
defect (middle portion of cartilage surface) is completely ﬁlled with the implanted material, which is covered with a PF. At the left-hand margin,
suture material is visible on top of the ﬂap. (B) MAS,200. Detail of the middle portion of the implanted area depicting the intersection between
the subchondral bone compartment and the implanted engineered cartilage. (C) MAS, 400. Detail of the central portion of the implanted
engineered cartilage. Abundant inhomogeneous extracellular matrix, relative sparsity of rounded chondrocytes (compare Fig. 2) occupying
well-deﬁned lacunae: beginning of columnar reorganization of chondrocytes in the remodeled cartilage 8 weeks after implantation.the critical duration of the entrapment time, but the similarity
of our arthroscopic ﬁndings at 4 and 8 weeks suggests that
the implants are adherent by the earlier juncture. We also
chose to restrict joint movement during the ﬁrst 4 postoper-
ative weeks, since free motion is associated with a high rate
of ﬂap loss36, while restriction of motion is associated with
improved ﬂap retention rates36,47.Arthroscopy was a good means of visualizing the super-
ﬁcial coverage of defects but it could not resolve the implant
itself. Low-ﬁeld MRI revealed edema of the subchondral
bone but yielded no useful information respecting the state
either of defect ﬁlling or of cartilage repair. A non-invasive
technique such as MRI would be an ideal method for mon-
itoring cartilage repair if the resolution was sufﬁciently high:Fig. 5. Integration of the successfully implanted engineered cartilage construct. The photomicrographs represent cuts of the same defect,
magniﬁcation 4. Histology staining with Masson’s Trichromic (A), Alcian blue (B), and immunohistochemical straining for collagen type I
(C) and collagen type II (D) was performed. The structures depicted are native cartilage (1), subchondral bone (2), engineered cartilage
(3) and periosteal material (4). All images show the similarity in the appearance of the native cartilage (1) and the implanted engineered car-
tilage construct (3), which exhibits strong staining for proteoglycans (B) and collagen II (D). This gives rise to the interpretation that implanted
material, which had been cultured in vitro, has survived in the host organism for 8 weeks. The difference between the cartilaginous implant and
the periosteal cover can best be appraised with the collagen staining (C, D), where an inverse relation is visible for the two tissue types. The
cartilaginous implant (3) stains intensely for collagen type II, and weakly for collagen type I, while the periosteal material (4) stains intensely for
collagen type I, while it is weak in collagen type II. Lateral and basal integrations of the implanted cartilage construct are good, as expressed
by the continuity in the staining from native cartilage (1) to the implanted construct (3). The PF is not bonded in the same way, as expressed by
the gap between the native cartilage (1) and the periosteal material (4) in picture B.
1224 W. Brehm et al.: Repair of superﬁcial osteochondral defectsfewer animals would be needed and more consistent results
could be obtained by following the same individual for a lon-
ger period of time. We are currently assessing the potential
of high-ﬁeld MRI observations by comparing them with his-
tologic ﬁndings, likewise in a goat model of cartilage repair.
As aforementioned, the implants were best retained when
covered with a PF. But this entrapment also apparently
prevented bone remodeling, which might be induced by
pro-inﬂammatory agents present within the synovial ﬂuid40.
In the group without a PF (group 1, PRP), a greater opening
of the tidemark was observed, which may have been
caused by an early loosening of the implant. Early access
of the synovial ﬂuid to the uncovered surface of the super-
ﬁcial osteochondral defect would permit the synovial ﬂuid to
penetrate into the subchondral bone layer. There, synovial
ﬂuid would cause reactions of the subchondral bone,
thereby further destroying the tidemark. The importance of
this signaling pathway in development of subchondral reac-
tions has been pointed out in the goat model also by
others40.
The use of an adhesive to ﬁx the implant basally (group 1)
did not improve either its retention or integration. The
human FG used here seemingly caused intense reactions
of the host, potentially indicating an immunologic reaction
to the xenograft material. However, some remnants of graft
material could be seen in histology also in these defects. A
PF alone yielded the best results, and future surgical efforts
should thus be directed toward achieving a good press ﬁt-
ting of the implant within the defect space. Alternatives to
the PF might also be sought. Ideally, the covering material
should be thin, smooth and biologically inactive. Periosteal
layers, which are of course biologically active52, may, at
a later postoperative juncture, compromise the cartilage
repair result. Possible alternatives might be absorbable syn-
thetic materials, such as polymer membranes with a short
half life, or collagenous membranes.
The integration of an implant with the surrounding native
cartilage and the underlying defect bed is always a major
problem. It has previously been described that the integra-
tive properties of tissue constructs cultured for up to 8
weeks in a bioreactor depend on their stage of development
at the time of implantation and, after implantation, on the
proteoglycan removal from the native cartilage abutting on
the defect space53. Although immature constructs have
poor mechanical properties at the onset, they integrate bet-
ter than either more mature ones or cartilage explants54.
This circumstance is attributable to the presence of prolifer-
ating and biosynthetically active cells54 and to the establish-
ment of cartilaginous tissue bonds. More mature constructs
deposit an extracellular matrix at the interface between the
implant and the surrounding native tissue. Immature
constructs also integrate better with the bone phase55.
The engineered implants used in the present study inte-
grated well with both the neighboring native cartilage (later-
ally) and the subchondral bone (basally). These hyaline
cartilage constructs have a higher cell density than mature
native tissue (Fig. 2), and this circumstance may account for
their good integrative properties.
Conclusion
The implantation of autologous, scaffold-free, engineered
cartilage constructs might best be performed beneath a PF
without the use of tissue adhesives.
In our caprine model, hyaline-like cartilage was mostly
observed in the defects 8 weeks after implantation of anautologous scaffold-free engineered cartilage implant.
Even at this early stage, the chondrocytes were beginning
to align themselves in vertical columns. Although the super-
ﬁcial osteochondral defect model used in the present study
does not totally correspond to the osteochondral one adop-
ted in our previous investigations with the same type of en-
gineered cartilage implants in the miniature pig30 and
rabbit31, the quality of the cartilage repair tissue formed
was similar. However, long-term studies in the goat model
have to be awaited for ﬁnal conclusion.
Autologous scaffold-free cartilage implants have great
potential to induce the repair of full-thickness cartilage de-
fects. The implantation technique involves no destruction
of the subchondral bone as occurs during mosaicplasty or
the implantation of osteochondral xenografts. Furthermore,
the purely autologous principle of our cartilage constructs
avoids any ethical issues relating to cell sources.
With this study, we provide a technical basis for long-term
animal experimentation and pilot clinical trials to evaluate
the efﬁcacy of this treatment strategy.
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